277 related articles for article (PubMed ID: 9599230)
1. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy.
Hu M; Brasseur N; Yildiz SZ; van Lier JE; Leznoff CC
J Med Chem; 1998 May; 41(11):1789-802. PubMed ID: 9599230
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and photodynamic activity of zinc(II) phthalocyanine derivatives bearing methoxy and trifluoromethylbenzyloxy substituents in homogeneous and biological media.
Yslas EI; Rivarola V; Durantini EN
Bioorg Med Chem; 2005 Jan; 13(1):39-46. PubMed ID: 15582450
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
Cauchon N; Ali H; Hasséssian HM; van Lier JE
Photochem Photobiol Sci; 2010 Mar; 9(3):331-41. PubMed ID: 20221459
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro photodynamic activities of di-alpha-substituted zinc(ii) phthalocyanine derivatives.
Liu JY; Lo PC; Jiang XJ; Fong WP; Ng DK
Dalton Trans; 2009 Jun; (21):4129-35. PubMed ID: 19452061
[TBL] [Abstract][Full Text] [Related]
6. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
7. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma.
Mosa M; Zitko M; Poucková P
Neoplasma; 1997; 44(3):178-83. PubMed ID: 9372860
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and phototherapeutic properties of Zinc (II) 2,9,16,23-tetrakis (methoxy) phthalocyanine in vivo.
Yslas EI; Prucca C; Romanini S; Durantini EN; Bertuzzi M; Rivarola V
Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):62-70. PubMed ID: 19447373
[TBL] [Abstract][Full Text] [Related]
9. Peripheral and axial substitution of phthalocyanines with solketal groups: synthesis and in vitro evaluation for photodynamic therapy.
Hofman JW; van Zeeland F; Turker S; Talsma H; Lambrechts SA; Sakharov DV; Hennink WE; van Nostrum CF
J Med Chem; 2007 Apr; 50(7):1485-94. PubMed ID: 17348640
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic properties of amphiphilic derivatives of aluminum tetrasulfophthalocyanine.
Allen CM; Langlois R; Sharman WM; La Madeleine C; Van Lier JE
Photochem Photobiol; 2002 Aug; 76(2):208-16. PubMed ID: 12194219
[TBL] [Abstract][Full Text] [Related]
11. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
Wei G; Huang L; Jiang Y; Shen Y; Huang Z; Huang Y; Sun X; Zhao C
Eur J Med Chem; 2019 May; 169():53-64. PubMed ID: 30856406
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic, toxicological and phototherapeutic studies of phthalocyanine ZnPcCF3.
Milla LN; Yslas EI; Cabral A; Durantini EN; Romanini S; Rivarola V; Bertuzzi M
Biomed Pharmacother; 2009 Mar; 63(3):209-15. PubMed ID: 18599256
[TBL] [Abstract][Full Text] [Related]
13. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C
Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724
[TBL] [Abstract][Full Text] [Related]
14. Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine.
Li L; Luo Z; Chen Z; Chen J; Zhou S; Xu P; Hu P; Wang J; Chen N; Huang J; Huang M
Bioconjug Chem; 2012 Nov; 23(11):2168-72. PubMed ID: 23057652
[TBL] [Abstract][Full Text] [Related]
15. Photokilling mechanisms induced by zinc(II)-phthalocyanine on cultured tumor cells.
Villanueva A; Domínguez V; Polo S; Vendrell VD; Sanz C; Cañete TM; Juarranz A; Stockert JC
Oncol Res; 1999; 11(10):447-53. PubMed ID: 10850885
[TBL] [Abstract][Full Text] [Related]
16. Octa-alkyl zinc phthalocyanines: potential photosensitizers for use in the photodynamic therapy of cancer.
Cook MJ; Chambrier I; Cracknell SJ; Mayes DA; Russell DA
Photochem Photobiol; 1995 Sep; 62(3):542-5. PubMed ID: 8570709
[TBL] [Abstract][Full Text] [Related]
17. Phthalocyanine-polyamine conjugates as highly efficient photosensitizers for photodynamic therapy.
Jiang XJ; Yeung SL; Lo PC; Fong WP; Ng DK
J Med Chem; 2011 Jan; 54(1):320-30. PubMed ID: 21138268
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, properties, and photodynamic inactivation of Escherichia coli using a cationic and a noncharged Zn(II) pyridyloxyphthalocyanine derivatives.
Scalise I; Durantini EN
Bioorg Med Chem; 2005 Apr; 13(8):3037-45. PubMed ID: 15781413
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
20. Zinc-(II) 2,9,16,23-tetrakis (methoxy) phthalocyanine: potential photosensitizer for use in photodynamic therapy in vitro.
Yslas EI; Durantini EN; Rivarola VA
Bioorg Med Chem; 2007 Jul; 15(13):4651-60. PubMed ID: 17467998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
